An Insight Into The Drug Resistance Profile And Mechanism Of Drug Resistance In Neisseria Gonorrhoeae

CONCLUSION
Despite a high prevalence of uncomplicated gonorrhea and an increasing incidence of resistant isolate of N. gonorrhea throughout the world, a standardized monitoring of the antimicrobial susceptibility profile has been resisted to gonococcus isolated surveillance project (GISP) in unites state and other association in other countries.  There is a need for better control of gonococci disease including enhanced global surveillance of resistance and improved treatment.
    It has been observed that the single dose approach has also contributed to the ability of N. gonorrhea to develop resistance to common used, inexpensive and effective drugs. The transmissibility of resistance genes has made the development of new antibiotics a challenging area of research but the laboratory base surveillance and susceptibility would be useful not only in deciding the correct treatment but also help to detect the emergence of new antibiotic resistant trait and to monitor the treatment. (Van Embden  et al, 1999). 
RECOMMENDATION
     Since the infection caused by Neisseria gonorrhea is prevalent to all antibiotic produces against it, therefore it has become imperative to initiate sustained national and international effort to reduce the infections and misuse of antimicrobial resistance. It is necessary not only to monitor drug resistance and optimism treatment regimens, but also to gain insight into how gonococcus develops drug resistance.